Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. | Blood | 2022 | 35977098 | PubTator, text mining | PubMed |
| Rh Phenotype and Allele Frequencies Among 88,856 Patients in China. | Clin Lab | 2022 | 35975497 | PubTator, text mining | PubMed |
| Red Blood Cell Immunization and Contributing Factors in 685 Thalassemia Patients. | Int J Hematol Oncol Stem Cell Res | 2022 | 35975116 | PubTator, text mining | PubMed |
| Serious hazards of transfusion: evaluating the dangers of a wrong patient autologous salvaged blood in cardiac surgery. | J Cardiothorac Surg | 2022 | 35974374 | PubTator, text mining | PubMed |
| B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign. | Front Immunol | 2022 | 35967439 | PubTator, text mining | PubMed |
| Regenerative medicine: prenatal approaches. | Lancet Child Adolesc Health | 2022 | 35963269 | PubTator, text mining | PubMed |
| Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination. | Int Immunopharmacol | 2022 | 35963158 | PubTator, text mining | PubMed |
| Mechanical Confinement and DDR1 Signaling Synergize to Regulate Collagen-Induced Apoptosis in Rhabdomyosarcoma Cells. | Adv Sci (Weinh) | 2022 | 35957513 | PubTator, text mining | PubMed |
| Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome? | J Clin Med | 2022 | 35956203 | PubTator, text mining | PubMed |
| A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma. | Int J Mol Sci | 2022 | 35955933 | PubTator, text mining | PubMed |
| Molecular basis of RhD-negative phenotype in North Indian blood donor population. | Indian J Med Res | 2022 | 35946206 | PubTator, text mining | PubMed |
| Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women. | Prenat Diagn | 2022 | 35933700 | PubTator, text mining | PubMed |
| Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma. | Cold Spring Harb Mol Case Stud | 2022 | 35933111 | PubTator, text mining | PubMed |
| Laboratory support of ABO antibody monitoring for ABO-incompatible solid organ transplantation. | Korean J Transplant | 2022 | 35919194 | PubTator, text mining | PubMed |
| Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway. | Nutrients | 2022 | 35893895 | PubTator, text mining | PubMed |
| Personal Freedom and Public Responsibility: Remaining Questions after First Case of HIV Transmission via Blood Transfusion in North Serbia. | Healthcare (Basel) | 2022 | 35893219 | PubTator, text mining | PubMed |
| FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis. | Antibodies (Basel) | 2022 | 35892705 | PubTator, text mining | PubMed |
| Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors in the Western Region of Saudi Arabia: A 7-Year Retrospective Analysis. | Medicina (Kaunas) | 2022 | 35888577 | PubTator, text mining | PubMed |
| Risks and Benefits of Prophylactic Transfusion before Cholecystectomy in Sickle Cell Disease. | J Clin Med | 2022 | 35887750 | PubTator, text mining | PubMed |
| Overcoming Methicillin-Resistance Staphylococcus aureus (MRSA) Using Antimicrobial Peptides-Silver Nanoparticles. | Antibiotics (Basel) | 2022 | 35884205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=41